Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bartkova

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Cancer Research|June 30, 2001
DNA damage-activated kinase Chk2 is independent of proliferation or differentiation yet correlates with tissue biologyC Lukas, J Bartkova, L Latella, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1991
Efficient immortalization of luminal epithelial cells from human mammary gland by introduction of simian virus 40 large tumor antigen with a recombinant retrovirusJ Bartek, J Bartkova, N Kyprianou, et al.
Blood|October 24, 1997
Cyclin D1 expression in mantle cell lymphoma is accompanied by downregulation of cyclin D3 and is not related to the proliferative activityM M Ott, J Bartkova, J Bartek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 31, 2013
Overabundant FANCD2, alone and combined with NQO1, is a sensitive marker of adverse prognosis in breast cancerR Fagerholm, K Sprott, T Heikkinen, et al.
The Journal of Cell Biology|April 29, 1998
A requirement for cyclin D3-cyclin-dependent kinase (cdk)-4 assembly in the cyclic adenosine monophosphate-dependent proliferation of thyrocytesF Depoortere, A Van Keymeulen, J Lukas, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Immunochemical analysis of the p53 oncoprotein in matched primary and metastatic human tumoursJ Bartkova, J Bartek, B Vojtesek, et al.
Oncogene|November 15, 2016
Tumors overexpressing RNF168 show altered DNA repair and responses to genotoxic treatments, genomic instability and resistance to proteotoxic stressK Chroma, M Mistrik, P Moudry, et al.
Oncogene|June 5, 2007
DNA damage response mediators MDC1 and 53BP1: constitutive activation and aberrant loss in breast and lung cancer, but not in testicular germ cell tumoursJ Bartkova, Z Horejsí, M Sehested, et al.
Oncogene|June 29, 2010
Replication stress and oxidative damage contribute to aberrant constitutive activation of DNA damage signalling in human gliomasJ Bartkova, P Hamerlik, M-T Stockhausen, et al.
Leukemia|January 1, 1997
Potential role for concurrent abnormalities of the cyclin D1, p16CDKN2 and p15CDKN2B genes in certain B cell non-Hodgkin's lymphomas. Functional studies in a cell line (Granta 519)D M Jadayel, J Lukas, E Nacheva, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Cancer Research|June 30, 2001
DNA damage-activated kinase Chk2 is independent of proliferation or differentiation yet correlates with tissue biologyC Lukas, J Bartkova, L Latella, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1991
Efficient immortalization of luminal epithelial cells from human mammary gland by introduction of simian virus 40 large tumor antigen with a recombinant retrovirusJ Bartek, J Bartkova, N Kyprianou, et al.
Blood|October 24, 1997
Cyclin D1 expression in mantle cell lymphoma is accompanied by downregulation of cyclin D3 and is not related to the proliferative activityM M Ott, J Bartkova, J Bartek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 31, 2013
Overabundant FANCD2, alone and combined with NQO1, is a sensitive marker of adverse prognosis in breast cancerR Fagerholm, K Sprott, T Heikkinen, et al.
The Journal of Cell Biology|April 29, 1998
A requirement for cyclin D3-cyclin-dependent kinase (cdk)-4 assembly in the cyclic adenosine monophosphate-dependent proliferation of thyrocytesF Depoortere, A Van Keymeulen, J Lukas, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Immunochemical analysis of the p53 oncoprotein in matched primary and metastatic human tumoursJ Bartkova, J Bartek, B Vojtesek, et al.
Oncogene|November 15, 2016
Tumors overexpressing RNF168 show altered DNA repair and responses to genotoxic treatments, genomic instability and resistance to proteotoxic stressK Chroma, M Mistrik, P Moudry, et al.
Oncogene|June 5, 2007
DNA damage response mediators MDC1 and 53BP1: constitutive activation and aberrant loss in breast and lung cancer, but not in testicular germ cell tumoursJ Bartkova, Z Horejsí, M Sehested, et al.
Oncogene|June 29, 2010
Replication stress and oxidative damage contribute to aberrant constitutive activation of DNA damage signalling in human gliomasJ Bartkova, P Hamerlik, M-T Stockhausen, et al.
Leukemia|January 1, 1997
Potential role for concurrent abnormalities of the cyclin D1, p16CDKN2 and p15CDKN2B genes in certain B cell non-Hodgkin's lymphomas. Functional studies in a cell line (Granta 519)D M Jadayel, J Lukas, E Nacheva, et al.
Pageof 7